DOCSLIB.ORG

(No Jab, No Pay) Bill 2015 Submission

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(No Jab, No Pay) Bill 2015 Submission Dear Senators, thank you for the opportunity to provide this submission. I believe that nobody should be compelled or coerced into receiving medical interventions, especially those that have faced no scientifically valid testing for safety or efficacy such as for vaccinations. In addition, there should be a Royal Commission into vaccine injury before any further vaccine related policies are considered. Do vaccines even work? All you have to do is ask yourself, what were the vaccines supposed to do? The polio vaccine for example wasn’t there so that less people could have polio viruses in their stools – that was never measured before or after and why would anybody care anyway? Its purpose of course was to reduce the number of paralysed or crippled children (other than through trauma). So we have to look at the total number of paralysed children before and after the vaccine to determine if it provided any useful benefit. If we look at polio diagnoses we run into the problem of what is known as diagnostic bias. This means that if the doctor knows the patient has received a treatment for a condition then this will prejudice their diagnosis of them. This is what the “double” in “randomised double blind placebo controlled trial is for” – so the results don’t artificially look positive for the treatment. The problem is though, there are no randomised double blind placebo controlled trials (using actual placebos and actual disease as a marker rather than antibody counts). All the evidence for their efficacy stems from historical epidemiological data which is subject to this diagnostic bias. To use an example to illustrate the point. A boy (let’s call him Johnny) has a rash and fever and his parents take him to the doctor. The doctor – seeing a rash and fever – says “I know what that is, it is measles”. To which the parents respond “but doctor, that isn’t possible because Johnny is fully immunised”. So the doctor checks Johnny’s immunisation records and sure enough, Johnny has had all the required shots. So what does the doctor do? He changes his diagnosis! He might call it, say, roseola or fifth disease instead. Now, if this happens on a regular enough basis (and it does) the result is that cases of measles falls dramatically even if the number of kids with a rash and fever hasn’t changed at all! Because of this pro-treatment (or diagnostic) bias the only valid way of measuring if the vaccine has worked is not to look at number of measles or polio or diphtheria or pertussis diagnoses but to look at the number of people with the characteristic symptoms or even more usefully, the number of people with severe complications thought to be caused by these diseases. To run through them: The purpose of the polio vaccine was to bring about a reduction in total rates of non-trauma paralysis and crippling. The purpose of the rubella vaccine was to bring about a reduction in total rates of congenital defects. The purpose of the measles vaccine was to bring about a reduction in total rates of encephalitis and deafness. The purpose of the Hep B vaccine was to bring about a reduction in total rates of liver cancer/disease. The purpose of the Hib and Prevnar vaccines was to bring about a reduction in total rates of meningitis/pneumonia/sepsis. The purpose of the diphtheria/pertussis vaccines was to bring about a reduction in acute respiratory infections. The purpose of the mumps vaccine was to reduce sterility. Now, in each of these cases (bar none) the vaccines appear to have failed. At least, from all the data I have looked at (in several countries that have had long running vaccine programs) there seems to be no obvious cases where the rates of any of these conditions has fallen dramatically since the vaccine. I have provided a sample of these statistics below. Note that most of them come from the United States which has the largest sample size and therefore is the most compelling but from what I can tell, the same story is reflected everywhere data is available. Rubella and congenital defects: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5701a2.htm. Polio and paralysis/crippling: extranet.who.int/polis/public/CaseCount.aspx and http://www.who.int/bulletin/archives/78(3)321.pdf (see data for total AFP in India and other developing countries in 1996 and again in 2014) as well as http://www.ssa.gov/policy/docs/ssb/v18n6/v18n6p20.pdf and http://www.census.gov/people/disability/ publications/sipp2010.html (Table A-4) (for disability rates). And http://www.christopherreeve.org/site/c.mtKZKgMWKwG/b.5184189/k.5587/Paralysis_Facts__Figur es.htm (Around one in 50 Americans have some paralysis and around 40 per cent of those cases are due to disease). Diphtheria/pertussis and acute respiratory disease: http://www.nejm.org/doi/full/10.1056/NEJMoa0804877 and http://www.pharmacytoday.co.nz/news/2015/may-2015/05/respiratory-hospitalisations-keep- climbing-despite-healthcare-improvements.aspx Hep B vaccine and liver cancer/disease: http://www.ncbi.nlm.nih.gov/pubmed/19224838 and http://news.sky.com/story/1418422/dramatic-rise-in-liver-disease-deaths Hib vaccine and meningitis/pneumonia/sepsis. http://www9.health.gov.au/cda/source/rpt_2.cfm... (look at meningococcal disease (invasive) and pneumococcal disease (invasive)) and because of the dismal failure of this vaccine it was inevitably followed by further attempts to vaccinate people against meningitis supposedly caused by other strains (eg Prevnar) showing that abject lunacy (doing the same thing over and over and expecting a different result) is the standard procedure for vaccination policy experts. Measles vaccine and encephalitis/deafness. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2870605/ and http://www.hear-it.org/35-million- Americans-suffering-from-hearing-loss So what has happened? Where did they all go if their complications still remain (and in some cases are more common than ever)? They were renamed. Measles has been renamed roseola, fifth disease, etc; Polio has been renamed Guillain Barre, transverse myelitis, coxsackie, MS, cerebral palsy (we actually use more respirators today than we ever did iron lungs by the way it is just that iron lungs were too expensive and dangerous to keep using); Diphtheria/pertussis were renamed respiratory syncytial virus, croup, strep, bronchiolitis etc; Hepatitis just keeps on running through the alphabet; Meningitis/pneumonia/sepsis blamed on Hib was renamed meningitis/pneumonia/sepsis blamed on some other bacteria; Smallpox was renamed monkey pox/severe chicken pox. All of the above are what are known as differential diagnoses – which means that doctors regularly get them confused. This is particularly pertinent because doctors will often differentially diagnose *today* by using laboratory testing (for example, if they find polio virus then they will diagnose polio but if they don’t find the virus they will diagnose, say, Guillain Barre). But of course, before the vaccine was introduced virus or bacteria testing of the patient was virtually non-existent. There would have been virtually no diphtheria patients in 1900 who were confirmed as having diphtheria with a laboratory but today, it would be impossible to diagnose someone as having diphtheria without such a confirmation. So the combination of the fact that doctors don’t want to diagnose these conditions and the stricter criteria required for diagnosing them has led to a dramatic reduction in their diagnoses but as you can see, no obvious improvement in the number of people suffering these symptoms. Are they safe? The amazing thing about this entire debate is that while proving vaccines work has some conceptual difficulties due to the fraught nature of statistics (ie the fact that they are prone to self-fulfilling prophecies as described above) it is incredibly easy for those who believe in the safety of the schedule to prove this once and for all without any equivocation. All they have to do is stand up in front of the population and take the entire infant immunisation schedule adjusted for their body weight. There is nothing remotely unusual about this. Indeed, if it were any other consumer product it would have been assumed to have been done time and time again. Nobody would trust a car if the CEO of the company that made it was too scared to hop in and drive it away. Nobody would trust the safety of food if the CEO of the company that made it pushed it away. And yet, when it comes to vaccinations, the one and only group that is expected to take the gruelling infant schedule are the infants themselves. No adult would touch the (equivalent) schedule with a bargepole. Given that this demonstration would, quite literally, end the questioning of vaccines then and there (even those of us who question their efficacy would see the vaccination issue as trivial) the only possible explanation of the fact that they refuse to do this demonstration is because they believe it would be astonishingly dangerous. To give an understanding of what our babies are expected to receive. The average adult male (85kg) would need to receive around 150 separate injections (plus the oral rotavirus doses) containing around 500 vaccines over the space of 18 months. It seems to me to be quite simple. If you would not subject yourself to that then there is no possible way you can justify compelling anybody else to get that amount for their babies. Now, there are some other highly disconcerting and irregular activities surrounding vaccine safety. For example, pharmaceutical companies are allowed to use non-inert controls in place of placebos.
Load more

Recommended publications
  • Roseola Fact Sheet
    Sixth Disease/ Exanthem Subitum DISTRICT OF COLUMBIA DEPARTMENT OF HEALTH Division of Epidemiology, Disease Surveillance and Investigation 899 N. Capitol Street, NE, Suite 580 Washington, D.C. 20002 202-442-9371 Fax 202-442-8060 * www.dchealth.dc.gov What is Roseola? medications. Frequent hand washing may Roseola is an acute, febrile rash illness caused by a limit transmission (spread). Women who are virus. pregnant and have been exposed to this illness should discuss the exposure with Who gets Fifth Disease? their doctor. Roseola occurs in children usually under four years of age. It is most common in children under the age Should a child with Roseola be excluded of two. from Child-care? Yes, a child with fever and rash should be What are the symptoms of Roseola? excluded from child-care until seen by a The symptoms of roseola include a high fever that health-care provider. The child may return lasts for three to five days. A runny nose, irritability, to child-care once the fever has gone, even if eyelid swelling, and tiredness may also be present. the rash is present. When the fever disappears, a rash appears, mainly on the face and body. How can Roseola be prevented? There is no vaccine or medicine that How is Roseola spread? prevents roseola. Frequent and thorough Roseola is spread from person to person but the hand washing is recommended as a practical exact way is not known. It appears that saliva may be and effective method of preventing most an important way for the spread of the virus.
    [Show full text]
  • Communicable Disease Chart
    COMMON INFECTIOUS ILLNESSES From birth to age 18 Disease, illness or organism Incubation period How is it spread? When is a child most contagious? When can a child return to the Report to county How to prevent spreading infection (management of conditions)*** (How long after childcare center or school? health department* contact does illness develop?) To prevent the spread of organisms associated with common infections, practice frequent hand hygiene, cover mouth and nose when coughing and sneezing, and stay up to date with immunizations. Bronchiolitis, bronchitis, Variable Contact with droplets from nose, eyes or Variable, often from the day before No restriction unless child has fever, NO common cold, croup, mouth of infected person; some viruses can symptoms begin to 5 days after onset or is too uncomfortable, fatigued ear infection, pneumonia, live on surfaces (toys, tissues, doorknobs) or ill to participate in activities sinus infection and most for several hours (center unable to accommodate sore throats (respiratory diseases child’s increased need for comfort caused by many different viruses and rest) and occasionally bacteria) Cold sore 2 days to 2 weeks Direct contact with infected lesions or oral While lesions are present When active lesions are no longer NO Avoid kissing and sharing drinks or utensils. (Herpes simplex virus) secretions (drooling, kissing, thumb sucking) present in children who do not have control of oral secretions (drooling); no exclusions for other children Conjunctivitis Variable, usually 24 to Highly contagious;
    [Show full text]
  • 10Neurodevelopmental Effects of Childhood Exposure to Heavy
    Neurodevelopmental E¤ects of Childhood Exposure to Heavy Metals: 10 Lessons from Pediatric Lead Poisoning Theodore I. Lidsky, Agnes T. Heaney, Jay S. Schneider, and John F. Rosen Increasing industrialization has led to increased exposure to neurotoxic metals. By far the most heavily studied of these metals is lead, a neurotoxin that is particularly dangerous to the developing nervous system of children. Awareness that lead poison- ing poses a special risk for children dates back over 100 years, and there has been increasing research on the developmental e¤ects of this poison over the past 60 years. Despite this research and growing public awareness of the dangers of lead to chil- dren, government regulation has lagged scientific knowledge; legislation has been in- e¤ectual in critical areas, and many new cases of poisoning occur each year. Lead, however, is not the only neurotoxic metal that presents a danger to children. Several other heavy metals, such as mercury and manganese, are also neurotoxic, have adverse e¤ects on the developing brain, and can be encountered by children. Al- though these other neurotoxic metals have not been as heavily studied as lead, there has been important research describing their e¤ects on the brain. The purpose of the present chapter is to review the neurotoxicology of lead poisoning as well as what is known concerning the neurtoxicology of mercury and manganese. The purpose of this review is to provide information that might be of some help in avoiding repeti- tion of the mistakes that were made in attempting to protect children from the dan- gers of lead poisoning.
    [Show full text]
  • Child Neurology: Hereditary Spastic Paraplegia in Children S.T
    RESIDENT & FELLOW SECTION Child Neurology: Section Editor Hereditary spastic paraplegia in children Mitchell S.V. Elkind, MD, MS S.T. de Bot, MD Because the medical literature on hereditary spastic clinical feature is progressive lower limb spasticity B.P.C. van de paraplegia (HSP) is dominated by descriptions of secondary to pyramidal tract dysfunction. HSP is Warrenburg, MD, adult case series, there is less emphasis on the genetic classified as pure if neurologic signs are limited to the PhD evaluation in suspected pediatric cases of HSP. The lower limbs (although urinary urgency and mild im- H.P.H. Kremer, differential diagnosis of progressive spastic paraplegia pairment of vibration perception in the distal lower MD, PhD strongly depends on the age at onset, as well as the ac- extremities may occur). In contrast, complicated M.A.A.P. Willemsen, companying clinical features, possible abnormalities on forms of HSP display additional neurologic and MRI abnormalities such as ataxia, more significant periph- MD, PhD MRI, and family history. In order to develop a rational eral neuropathy, mental retardation, or a thin corpus diagnostic strategy for pediatric HSP cases, we per- callosum. HSP may be inherited as an autosomal formed a literature search focusing on presenting signs Address correspondence and dominant, autosomal recessive, or X-linked disease. reprint requests to Dr. S.T. de and symptoms, age at onset, and genotype. We present Over 40 loci and nearly 20 genes have already been Bot, Radboud University a case of a young boy with a REEP1 (SPG31) mutation. Nijmegen Medical Centre, identified.1 Autosomal dominant transmission is ob- Department of Neurology, PO served in 70% to 80% of all cases and typically re- Box 9101, 6500 HB, Nijmegen, CASE REPORT A 4-year-old boy presented with 2 the Netherlands progressive walking difficulties from the time he sults in pure HSP.
    [Show full text]
  • Accelerating Research. Empowering Families
    RESEARCH STRATEGY AND MISSION We aggressively pursue research to identify treatments and a cure for Rett syndrome. New Mecp2 female mouse model developed AMO receives FDA Orphan Drug Designation 2018 + BEYOND With your support, we can Neuren begins plans for trofinetide Phase 3 continue to blaze a trail in Rett syndrome research and family 2017 14 clinics designated empowerment to transform lives. as Rett Syndrome Clinical Research First multi-site, Centers of Excellence multi-country clinical Join us in our mission: trial begins: sarizotan • Make a donation 2015 • Coordinate a Fundraiser Clinical trial for • Participate in an Event trofinetide begins • Advocate for Rett syndrome NIH funding of the NHS begins Visit www.rettsyndrome.org or Drug screening Scout program begins call 1.800.719.8214 2014 First multi-site clinical trial Rettsyndrome.org is a 501(c)3 organization in RTT begins: NNZ-2566 (trofinetide) Accelerating dedicated to accelerating research for treatments and a cure for Rett syndrome and related disorders, 2013 while providing family empowerment. As a Established stem Research. leading organization for Rett syndrome research, cell model for Rettsyndrome.org is committed to funding high- drug screening First clinical trial quality, peer-reviewed research grants and programs. in RTT supported by Rettsyndrome.org: IGF-1 Empowering Genetic manipulation 2010 and biochemical Families. intervention improve Rett-like symptoms in a mouse model 2007 4600 Devitt Drive Cincinnati, OH 45246-1104 ‘‘ (800) 818-7388 www.rettsyndrome.org I am very thankful that Rettsyndrome.org has taken such a strong leadership role /rettsyndrome /rettsyndrome /rettsyndromeorg with advancing research. Their progress to get trofinetide to market is very exciting as it could finally be an answer to relieving some of Jill’s daily struggles.
    [Show full text]
  • Hereditary Spastic Paraparesis: a Review of New Developments
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.69.2.150 on 1 August 2000. Downloaded from 150 J Neurol Neurosurg Psychiatry 2000;69:150–160 REVIEW Hereditary spastic paraparesis: a review of new developments CJ McDermott, K White, K Bushby, PJ Shaw Hereditary spastic paraparesis (HSP) or the reditary spastic paraparesis will no doubt Strümpell-Lorrain syndrome is the name given provide a more useful and relevant classifi- to a heterogeneous group of inherited disorders cation. in which the main clinical feature is progressive lower limb spasticity. Before the advent of Epidemiology molecular genetic studies into these disorders, The prevalence of HSP varies in diVerent several classifications had been proposed, studies. Such variation is probably due to a based on the mode of inheritance, the age of combination of diVering diagnostic criteria, onset of symptoms, and the presence or other- variable epidemiological methodology, and wise of additional clinical features. Families geographical factors. Some studies in which with autosomal dominant, autosomal recessive, similar criteria and methods were employed and X-linked inheritance have been described. found the prevalance of HSP/100 000 to be 2.7 in Molise Italy, 4.3 in Valle d’Aosta Italy, and 10–12 Historical aspects 2.0 in Portugal. These studies employed the In 1880 Strümpell published what is consid- diagnostic criteria suggested by Harding and ered to be the first clear description of HSP.He utilised all health institutions and various reported a family in which two brothers were health care professionals in ascertaining cases aVected by spastic paraplegia. The father was from the specific region.
    [Show full text]
  • Caspr2 Antibodies in Patients with Thymomas
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector MALIGNANCIES OF THE THYMUS Caspr2 Antibodies in Patients with Thymomas Angela Vincent, FRCPath,* and Sarosh R. Irani, MA* neuromuscular junction. Neuromyotonia (NMT) is due to Abstract: Myasthenia gravis is the best known autoimmune disease motor nerve hyperexcitability that leads to muscle fascicula- associated with thymomas, but other conditions can be found in tions and cramps. A proportion of patients have antibodies patients with thymic tumors, including some that affect the central that appear to be directed against brain tissue-derived volt- nervous system (CNS). We have become particularly interested in age-gated potassium channels (VGKCs) that control the ax- patients who have acquired neuromyotonia, the rare Morvan disease, onal membrane potential.4,5 VGKC antibody titers are rela- or limbic encephalitis. Neuromyotonia mainly involves the periph- tively low in NMT. eral nerves, Morvan disease affects both the peripheral nervous Morvan disease is a rare condition first described in system and CNS, and limbic encephalitis is specific to the CNS. 1876 but until recently hardly mentioned outside the French Many of these patients have voltage-gated potassium channel auto- literature.6 The patients exhibit NMT plus autonomic distur- antibodies. All three conditions can be associated with thymomas bance (such as excessive sweating, constipation, and cardiac and may respond to surgical removal of the underlying tumor
    [Show full text]
  • Cerebral Palsy the ABC's of CP
    Cerebral Palsy The ABC’s of CP Toni Benton, M.D. Continuum of Care Project UNM HSC School of Medicine April 20, 2006 Cerebral Palsy Outline I. Definition II. Incidence, Epidemiology and Distribution III. Etiology IV. Types V. Medical Management VI. Psychosocial Issues VII. Aging Cerebral Palsy-Definition Cerebral palsy is a symptom complex, (not a disease) that has multiple etiologies. CP is a disorder of tone, posture or movement due to a lesion in the developing brain. Lesion results in paralysis, weakness, incoordination or abnormal movement Not contagious, no cure. It is static, but it symptoms may change with maturation Cerebral Palsy Brain damage Occurs during developmental period Motor dysfunction Not Curable Non-progressive (static) Any regression or deterioration of motor or intellectual skills should prompt a search for a degenerative disease Therapy can help improve function Cerebral Palsy There are 2 major types of CP, depending on location of lesions: Pyramidal (Spastic) Extrapyramidal There is overlap of both symptoms and anatomic lesions. The pyramidal system carries the signal for muscle contraction. The extrapyramidal system provides regulatory influences on that contraction. Cerebral Palsy Types of brain damage Bleeding Brain malformation Trauma to brain Lack of oxygen Infection Toxins Unknown Epidemiology The overall prevalence of cerebral palsy ranges from 1.5 to 2.5 per 1000 live births. The overall prevalence of CP has remained stable since the 1960’s. Speculations that the increased survival of the VLBW preemies would cause a rise in the prevalence of CP have proven wrong. Likewise the expected decrease in CP as a result of C-section and fetal monitoring has not happened.
    [Show full text]
  • Clinical Impact of Primary Infection with Roseoloviruses
    Available online at www.sciencedirect.com ScienceDirect Clinical impact of primary infection with roseoloviruses 1 2 1 Brenda L Tesini , Leon G Epstein and Mary T Caserta The roseoloviruses, human herpesvirus-6A -6B and -7 (HHV- infection in different cell types, have the ability to reac- 6A, HHV-6B and HHV-7) cause acute infection, establish tivate, and may be intermittently shed in bodily fluids [3]. latency, and in the case of HHV-6A and HHV-6B, whole virus Unlike other human herpesviruses, HHV-6A and HHV- can integrate into the host chromosome. Primary infection with 6B are also found integrated into the host genome HHV-6B occurs in nearly all children and was first linked to the (ciHHV-6). Integration has been documented in 0.2– clinical syndrome roseola infantum. However, roseolovirus 1% of the general population and along with latency infection results in a spectrum of clinical disease, ranging from has confounded the ability to correlate the presence of asymptomatic infection to acute febrile illnesses with severe viral nucleic acid with active disease [4]. neurologic complications and accounts for a significant portion of healthcare utilization by young children. Recent advances The syndrome known as roseola infantum was reported as have underscored the association of HHV-6B and HHV-7 early as 1809 by Robert Willan in his textbook ‘On primary infection with febrile status epilepticus as well as the cutaneous diseases’ [5]. This clinical entity is also com- role of reactivation of latent infection in encephalitis following monly referred to as exanthem subitum and early pub- cord blood stem cell transplantation.
    [Show full text]
  • Neurosyphilis Presenting with Myelitis-Case Series and Literature Review
    Neurosyphilis presenting with myelitis-Case series and literature review Yali Wu Capital Medical University Aliated Beijing Ditan Hospital https://orcid.org/0000-0002-9737-6439 Wenqing Wu ( [email protected] ) https://orcid.org/0000-0001-7428-5529 Case report Keywords: Syphilis, Neurosyphilis, Spinal cord, Magnetic resonance imaging Posted Date: April 5th, 2019 DOI: https://doi.org/10.21203/rs.2.1849/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published at Journal of Infection and Chemotherapy on February 1st, 2020. See the published version at https://doi.org/10.1016/j.jiac.2019.09.007. Page 1/9 Abstract Background Neurosyphilis is a great imitator because of its various clinical symptoms. Syphilitic myelitis is extremely rare manifestation of neurosyphilis and often misdiagnosed. However, a small amount of literature in the past described its clinical manifestations and imaging features, and there was no relevant data on the prognosis, especially the long-term prognosis. In this paper, 4 syphilis myelitis patients admitted to our hospital between July 2012 and July 2017 were retrospectively reviewed. In the 4 patients, 2 were females, and 2 were males. We present our experiences with syphilitic myelitis, discuss the characteristics, treatment and prognosis. Case presentation The diagnosis criteria were applied: (1) diagnosis of myelitis established by two experienced neurologist based on symptoms and longitudinally extensive transverse myelitis (LETM) at the cervical and thoracic levels mimicked neuromyelitis optic (NMO) on magnetic resonance imaging (MRI) ; (2) Neurosyphilis (NS) was diagnosed by positive treponema pallidum particle assay (TPPA) and toluidine red untreated serum test (TRUST) in the serum and CSF; (3) negative human immunodeciency virus (HIV).
    [Show full text]
  • Measles Diagnostic Tool
    Measles Prodrome and Clinical evolution E Fever (mild to moderate) E Cough E Coryza E Conjunctivitis E Fever spikes as high as 105ºF Koplik’s spots Koplik’s Spots E E Viral enanthem of measles Rash E Erythematous, maculopapular rash which begins on typically starting 1-2 days before the face (often at hairline and behind ears) then spreads to neck/ the rash. Appearance is similar to “grains of salt on a wet background” upper trunk and then to lower trunk and extremities. Evolution and may become less visible as the of rash 1-3 days. Palms and soles rarely involved. maculopapular rash develops. Rash INCUBATION PERIOD Fever, STARTS on face (hairline & cough/coryza/conjunctivitis behind ears), spreads to trunk, Average 8-12 days from exposure to onset (sensitivity to light) and then to thighs/ feet of prodrome symptoms 0 (average interval between exposure to onset rash 14 day [range 7-21 days]) -4 -3 -2 -1 1234 NOT INFECTIOUS higher fever (103°-104°) during this period rash fades in same sequence it appears INFECTIOUS 4 days before rash and 4 days after rash Not Measles Rubella Varicella cervical lymphadenopathy. Highly variable but (Aka German Measles) (Aka Chickenpox) Rash E often maculopapular with Clinical manifestations E Clinical manifestations E Generally mild illness with low- Mild prodrome of fever and malaise multiforme-like lesions and grade fever, malaise, and lymph- may occur one to two days before may resemble scarlet fever. adenopathy (commonly post- rash. Possible low-grade fever. Rash often associated with painful edema hands and feet. auricular and sub-occipital).
    [Show full text]
  • Epilepsy and Cerebral Palsy*
    Arch Dis Child: first published as 10.1136/adc.31.155.1 on 1 February 1956. Downloaded from EPILEPSY AND CEREBRAL PALSY* BY BRIAN H. KIRMAN From the Fountain Hospital, Tooting, London (RECEIVED FOR PUBLICATION SEPTEMBER 6, 1955) The two conditions epilepsy and palsy in its Frequency of Epilepsy as a Complication many forms are amongst the earliest syndromes of Cerebral Palsy recorded in history. The association between Brissaud and Souques (1904) attempted to confine epilepsy and cerebral palsy in childhood is a matter the term 'Little's disease' to those cases not com- of everyday experience, and this association is of plicated by fits or mental defect, but Little's (1861-2) scientific interest as throwing light on the nature of own description of 63 cases refers specifically to the cerebral palsy and, more particularly, of epilepsy. complication ofconvulsions. Kinnier Wilson (1940) It is also of practical importance in view of recent refers to Little's disease not as 'an ailment of a well efforts to make more adequate provision for those defined character but a mere syndrome and a rather children with cerebral palsy who are educable. wide-ranging one at that'. Since epilepsy is also The existence of the two conditions in one child not a disease but a symptom of cerebral dysfunction constitutes a double handicap. The present ten- it is understandable that cerebral palsy and epilepsy dency in our educational system is for ever-increasing should often be encountered in the same patient. copyright. subdivision of educational 'types', and any child Kinnier Wilson states that in his experience 30% of who is difficult to fit into one of the artificial cate- cases of cerebral diplegia have fits which may be gories thus constructed is in danger of remaining general or one-sided.
    [Show full text]